Can intravenous immunoglobulin be administered continuously?
IVIG usually refers to intravenous immunoglobulin. Whether patients can receive consecutive intravenous immunoglobulin treatments depends on the severity of their condition.
Intravenous immunoglobulin has dual functions of immune replacement and immune modulation. It is primarily used to prevent viral infections such as measles and hepatitis A. It helps enhance the body's immunity and assists in fighting infections and diseases. Patients with mild infections generally should not receive consecutive treatments, as high doses may cause side effects such as headache and nausea. Such patients are usually advised to improve their natural immunity through healthy lifestyle practices, including balanced diets and regular sleep patterns.
However, for patients with severe infections, doctors may consider consecutive administration based on individual circumstances. They will closely monitor the patient's condition, gradually reduce the frequency of administration, and adjust the treatment plan accordingly.
For patients with other underlying medical conditions, the decision to administer consecutive intravenous immunoglobulin treatments would require more cautious evaluation. If any discomfort or adverse symptoms occur during treatment, prompt medical attention is recommended.